Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
VIP:Visual-Valid Dietary Behavior Pattern Recognition for Local-National Trials
Role of the gut microbiota in shaping severity of malaria
Repairing maladaptive corticospinal tract development
Telomeres and lung cancer incidence and survival
Deletions in Mitochondrial DNA with Aging
Recently added grants:
Synaptic changes and hypersynchronous network activity in mTORopathies
Endoplasmic Reticulum Stress Responses in Pain
Development of a deep neural network to measure spontaneous pain from mouse facial expressions
Sushi domain proteins as synapse protective factors in brain development and aging
Ciliary Disassembly, a modifier of Autosomal Dominant Polycystic Kidney Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67186-2-0-1
Application #
7574878
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Children's Hospital & Res Ctr at Oakland
$366,202
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Morris, Claudia /
$359,807
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant